Sangyong Jon

Sangyong Jon is a Professor in the BIO department at KAIST. His research interests include Bioengineering, Cancer Biology, Drug Delivery, Immunology, and Stem Cell. He leads the Bio-Nanomedicine Lab, where his team focuses on developing nanomedicine solutions for various diseases. His work includes the development of glyconanoparticles, nanovaccines, and smart drug delivery systems. Jon's research has been featured in several news articles highlighting advancements in cancer treatment and inflammatory bowel disease therapies.

Sangyong Jon is a Full Professor in the Department of Biological Sciences at KAIST, specializing in nanomedicine, drug delivery, biologics, and immunotherapy. His research focuses on developing innovative nanotechnology-based approaches for targeted cancer therapy and imaging. Jon's work includes the design of nanoparticle-aptamer bioconjugates for precise drug delivery and combined imaging and therapeutic applications. He has also explored the use of superparamagnetic iron oxide nanoparticles and quantum dot-aptamer conjugates for enhanced cancer diagnostics and treatment. His research emphasizes the development of multifunctional nanomaterials for improving therapeutic outcomes and reducing side effects in clinical settings.